0.7444
price down icon1.01%   -0.0076
after-market After Hours: .75 0.0056 +0.75%
loading
Assertio Holdings Inc stock is traded at $0.7444, with a volume of 244.49K. It is down -1.01% in the last 24 hours and down -15.49% over the past month. Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$0.752
Open:
$0.7402
24h Volume:
244.49K
Relative Volume:
0.95
Market Cap:
$71.64M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
-0.3685
EPS:
-2.02
Net Cash Flow:
$70.07M
1W Performance:
-9.23%
1M Performance:
-15.49%
6M Performance:
+14.59%
1Y Performance:
-27.73%
1-Day Range:
Value
$0.73
$0.7644
1-Week Range:
Value
$0.73
$0.82
52-Week Range:
Value
$0.5137
$1.08

Assertio Holdings Inc Stock (ASRT) Company Profile

Name
Name
Assertio Holdings Inc
Name
Phone
(224) 419-7106
Name
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Name
Employee
30
Name
Twitter
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
ASRT's Discussions on Twitter

Compare ASRT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ASRT
Assertio Holdings Inc
0.7444 72.37M 169.43M -186.01M 70.07M -2.02
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-26-24 Initiated Maxim Group Buy
Jul-03-24 Initiated H.C. Wainwright Buy
Nov-07-22 Initiated Lake Street Buy
Nov-30-18 Downgrade Mizuho Buy → Neutral

Assertio Holdings Inc Stock (ASRT) Latest News

pulisher
06:19 AM

Will Assertio Holdings Inc. stock sustain high P E ratiosJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com

06:19 AM
pulisher
06:16 AM

Why Assertio Holdings Inc. stock appeals to dividend seekersGold Moves & Real-Time Chart Breakout Alerts - newser.com

06:16 AM
pulisher
06:15 AM

Intraday pattern recognizer results for Assertio Holdings Inc.July 2025 Breakouts & Verified Chart Pattern Signals - newser.com

06:15 AM
pulisher
06:00 AM

How Assertio Holdings Inc. stock compares to market leadersWeekly Trade Recap & High Accuracy Trade Alerts - newser.com

06:00 AM
pulisher
05:36 AM

Can Assertio Holdings Inc. recover in the next quarterWatch List & AI Driven Stock Price Forecasts - newser.com

05:36 AM
pulisher
05:22 AM

Key metrics from Assertio Holdings Inc.’s quarterly data2025 Earnings Surprises & Long-Term Investment Growth Plans - newser.com

05:22 AM
pulisher
05:06 AM

Using R and stats models for Assertio Holdings Inc. forecasting2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - newser.com

05:06 AM
pulisher
04:46 AM

Applying Elliott Wave Theory to Assertio Holdings Inc.2025 Retail Activity & AI Forecasted Stock Moves - newser.com

04:46 AM
pulisher
03:47 AM

Will Assertio Holdings Inc. stock benefit from AI adoptionShort Setup & Smart Swing Trading Alerts - newser.com

03:47 AM
pulisher
02:47 AM

Using AI based signals to follow Assertio Holdings Inc.July 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com

02:47 AM
pulisher
02:14 AM

Why Assertio Holdings Inc. stock is seen as undervaluedJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com

02:14 AM
pulisher
Oct 30, 2025

What does recent volatility data suggest for Assertio Holdings Inc.2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Using Ichimoku Cloud for Assertio Holdings Inc. technicals2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How to manage a losing position in Assertio Holdings Inc.July 2025 Review & Target Return Focused Picks - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is Assertio Holdings Inc. stock oversold or undervaluedWeekly Risk Summary & Safe Entry Momentum Stock Tips - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Assertio names Mark Reisenauer as new CEO, effective immediately - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Assertio Announces Leadership Transition - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Assertio (Nasdaq: ASRT) sets Q3 results Nov. 10; expects guidance update within the current range - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

How Assertio Holdings Inc. stock reacts to global recession fearsEarnings Risk Summary & Weekly Breakout Watchlists - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Will Assertio Holdings Inc. stock benefit from infrastructure spendingJuly 2025 Closing Moves & Low Risk High Reward Trade Ideas - Fundação Cultural do Pará

Oct 28, 2025

Assertio Holdings Inc Stock (ASRT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Assertio Holdings Inc Stock (ASRT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Schlessinger Sam
EVP, General Counsel
May 12 '25
Option Exercise
0.00
38,017
0
191,906
Schwichtenberg Paul
See Remarks
May 12 '25
Option Exercise
0.00
38,017
0
184,362
Patel Ajay
EVP and CFO
May 12 '25
Option Exercise
0.00
38,017
0
213,692
Schlessinger Sam
SVP, General Counsel
Feb 21 '25
Option Exercise
0.00
17,150
0
161,545
Schwichtenberg Paul
See Remarks
Feb 21 '25
Option Exercise
0.00
17,150
0
154,850
Patel Ajay
SVP and CFO
Feb 21 '25
Option Exercise
0.00
17,150
0
184,180
Schlessinger Sam
SVP, General Counsel
Feb 07 '25
Option Exercise
0.00
21
0
153,698
Schwichtenberg Paul
See Remarks
Feb 07 '25
Option Exercise
0.00
25,000
0
150,101
Patel Ajay
SVP and CFO
Feb 07 '25
Option Exercise
0.00
25,000
0
179,431
Mason Heather L
Director
Nov 18 '24
Buy
0.80
75,000
60,000
287,650
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):